Jennifer Doudna, Fyodor Urnov talk need for standard gene editing playbook ahead of new Danaher initiative

Jennifer Doudna wants to create a new blueprint for developing gene editing therapies for rare diseases — an area where there’s been limited diversity in the conditions being addressed because many aren’t seen as profitable.

The Innovative Genomics Institute, a non-profit founded by Doudna, is partnering with life science tools…
Click here to view original post